You are here: Industry Insights > Repurposing

News List

New Drugs for Old: Repurposing and Repositioning Pharmaceuticals Suzanne Elvidge
July 15, 2024
Drug repurposing and repositioning offers a cost effective and efficient route to the market that allows patients to get access to drugs more quickly.
Repurposing a familiar drug for COVID-19 WorldPharmaNews
November 18, 2021
For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines.
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing prnasia
May 19, 2021
Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ...
Drug repurposing can shorten drug development timelines, experts tell CPhI Discover audience cphi-online
May 19, 2021
Drug repurposing can shorten drug development timelines via regulatory pathways which expedite the approval process because they avoid duplication of studies previously performed on the drug, according to experts speaking at the CPhI Discover webinar, Dru
Hyundai Bioscience leads in the repurposing of Niclosamide prnasia
April 09, 2021
A research paper by a South Korean bio tech company that demonstrated the drug repurposing of Niclosamide, an anthelmintic known to have excellent therapeutic efficacy against novel coronavirus infection (COVID-19), was published in the world-renowned ...
Syntekabio, Hanmi to Co-Develop COVID-19 Treatments Using Drug Repurposing Technologies americanpharmaceuticalreview
January 27, 2021
Syntekabio and Hanmi Science have entered into a strategic collaboration to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData expresspharma
August 19, 2020
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical trials and final drug authorization.
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData expresspharma
June 03, 2020
The Drug Controller General of India (DCGI) has recently given approval to Indian pharma companies Glenmark and Strides Pharma Science to initiate clinical trials of favipiravir for COVID-19 patients.
Scientists discover 59 repurposing drug candidates for COVID-19 pharmatimes
May 14, 2020
As of this morning – Thursday May 14 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 229,705 with 33,186 deaths.
CSIR identifies top 25 drugs/drug candidates for repurposing expresspharma
May 04, 2020
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs.